G01N 2333/8125
Alpha-1-antitrypsin
G01N2333/8125 (Alpha-1-antitrypsin) appears on 137 US grants and 95 published applications in this corpus.
Search patents in G01N- Granted patents
- 137
- Published applications
- 95
- Assignees
- 61
- Inventors
- 200
- Latest grant
- 30 Dec 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1986 | 1 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 1 | 0 |
| 1994 | 1 | 0 |
| 1995 | 4 | 0 |
| 1996 | 8 | 0 |
| 1997 | 19 | 0 |
| 1998 | 31 | 0 |
| 1999 | 7 | 0 |
| 2000 | 8 | 0 |
| 2001 | 9 | 0 |
| 2002 | 4 | 3 |
| 2003 | 2 | 10 |
| 2004 | 5 | 8 |
| 2005 | 2 | 4 |
| 2006 | 2 | 4 |
| 2007 | 2 | 3 |
| 2008 | 3 | 2 |
| 2009 | 0 | 4 |
| 2010 | 0 | 6 |
| 2011 | 1 | 5 |
| 2012 | 2 | 3 |
| 2013 | 3 | 4 |
| 2014 | 1 | 3 |
| 2015 | 3 | 4 |
| 2016 | 3 | 5 |
| 2017 | 1 | 2 |
| 2018 | 4 | 2 |
| 2019 | 1 | 0 |
| 2020 | 2 | 1 |
| 2021 | 2 | 1 |
| 2022 | 0 | 4 |
| 2023 | 0 | 4 |
| 2024 | 1 | 4 |
| 2025 | 2 | 6 |
| 2026 | 0 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- System for insurance underwriting and post policy issuance action30 Dec 2025US 12,512,191 B2
- Method of screening for a chronic kidney disease or glomerulopathy method of monitoring a response to treatment of a chronic kidney disease or glomerulopathy in a subject and a method of treatment of a chronic kidney disease or glomerulopathy21 Oct 2025US 12,449,426 B2Instytut Biochemii I Biofizyki Pan
- Alpha-1 antitrypsin (AAT) RNAi agents, compositions including AAT RNAi agents, and methods of use30 Jan 2024US 11,884,920 B2Arrowhead Pharmaceuticals, Inc.
- Alpha-1 antitrypsin (AAT) RNAi agents, compositions including AAT RNAi agents, and methods of use21 Dec 2021US 11,203,756 B2Arrowhead Pharmaceuticals, Inc.
- Methods and kits for detecting misfolded proteins21 Sep 2021US 11,125,758 B2The Regents of the University of California
- Glycoprotein biomarkers for ovarian cancer diagnosis1 Oct 2026US 2026/0298932 A1Proseek Bio Pty Ltd.
- Use of kit for diagnosing or assisting in diagnosis of spn1 Oct 2026US 2026/0298937 A1Junmo (Beijing) Biotherapeutics Co., Ltd.
- Depletion of high-abundance plasma proteins using in situ growth of metal-organic frameworks (mofs) for proteomic analysis and biomarker discovery10 Sep 2026US 2026/0266814 A1
- Neutralization antibody assay method18 Dec 2025US 2025/0383363 A1Merck Sharp & Dohme Corp.
- Bladder cancer biomarkers and methods of use2 Oct 2025US 2025/0305057 A1Nonagen Bioscience Corporation
Most cited
By later US patents
- Methods for identifying nucleic acid ligands856US 5,270,163 AUniversity Research Corporation · 1993
- Nucleic acid ligands561US 5,475,096 AUniversity Research Corporation · 1995
- Systematic evolution of ligands by exponential enrichment: Solution SELEX337US 5,567,588 AUniversity Research Corporation · 1996
- Systematic evolution of ligands by exponential enrichment: chimeric selex281US 5,637,459 ANeXstar Pharmaceuticals, Inc. · 1997
- High-affinity nucleic acid ligands that discriminate between theophylline and caffeine277US 5,580,737 ANeXstar Pharmaceuticals, Inc. · 1996